Cargando…
Nightmares and Mirtazapine—Time to be vigilant
Autores principales: | Sudha TY, Sree, VenkataNaga, Saritha, Thangaraju, Pugazhenthan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8450730/ https://www.ncbi.nlm.nih.gov/pubmed/34584314 http://dx.doi.org/10.1177/0253717620926785 |
Ejemplares similares
-
Nightmares with mirtazapine - A case report
por: Kavoor, Anjana Rao, et al.
Publicado: (2020) -
Be vigilant in treating a patient with diabetes and COVID-19-associated mucormycosis
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023) -
Paediatric dosage ‘need of hours among family physicians/other speciality physicians’
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2022) -
Need for vigilance monitoring regarding neurological disorders post-COVID vaccination
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2023) -
Vigilance in selection of low-dose versus high-dose steroids in COVID-19
por: Thangaraju, Pugazhenthan, et al.
Publicado: (2021)